Rapidly Adaptable Antibacterial Agents for Treating Multidrug Resistant Infections,
Chief Scientific Officer, Circle Pharma
Rapidly Adaptable Antibacterial Agents for Treating Multidrug Resistant Infections,
Techulon Inc
Discovery of functional ligands and materials from genetically-encoded libraries of chemically-modified peptides,
University of Alberta
Targeting protein-protein interactions with engineered cyclotides,
University of Southern California
Controlling Autoimmune Diseases Using Bifunctional Peptide Inhibitors (BPI),
University of Kansas
The Discovery and Preclinical Development of MTI-101, a Cyclic Beta-Hairpin Peptide with in Vivo Activity Against Myeloma and Lung Cancer.,
Executive Vice President, Modulation Therapeutics Incorporated
Intranasal Delivery of Peptide Therapeutics: Challenges and Strategies,
Scientist, MedImmune
Macrocyclic Peptide Drug Discovery: Protein-Protein Interaction Target Space,
Distinguished Scientist & Head, Peptide Drug Discovery and Innovative Technologies, Merck Research Laboratories
Peptide macrocyclization enabled by cysteine arylation,
Assistant Professor of Chemistry, Massachusetts Institute of Technology
Antimicrobial Peptides: Innate Defense Against Ocular Surface Pathogens and Potential Therapeutic Use,
University of Houston